Content area
Full text
A jury in the U.S. District Court for the Southern District of California ruled last week that the Santee-based maker of a diagnostics test Scantibodies Clinical Laboratory, Inc. and Scantibodies Laboratory, Inc. did not infringe a patent belonging to Nichols Institute Diagnostics, Inc., a unit of diagnostic firm Quest Diagnostics, Inc. of Lyndhurst, N.J.
Nichols has long been the market leader with a test to measure parathyroid hormone levels, which doctors rely on to treat patients with kidney disease, said David Doyle, who was the lead...